EU Panel Recommends Luxturna for Inherited Retinal Dystrophy

The EMA's CHMP has recommended marketing authorization for voretigene neparvovec for inherited retinal dystrophy caused by RPE65 gene mutations in adults and children.
International Approvals

Full Story →